ADAR1 Capital Management, LLC - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for Inhibikase Therapeutics, Inc. (IKT)

Filing Manager
ADAR1 Capital Management, LLC
Reporting Manager
ADAR1 Capital Management GP, LLC
Security
Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
IKT
Shares outstanding
70M shares
Disclosed Ownership
6.99M shares
Ownership
9.99%
Form type
SCHEDULE 13G
Date filed
2/14/2025, 09:04 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ADAR1 Capital Management, LLC 9.99% 6.81M 0 6.81M /s/ Daniel Schneeberger Daniel Schneeberger, Manager
ADAR1 Capital Management GP, LLC 9.99% 6.99M 0 6.99M /s/ Daniel Schneeberger Daniel Schneeberger, Manager
Daniel Schneeberger 9.99% 6.81M 0 6.81M /s/ Daniel Schneeberger Daniel Schneeberger, in his individual capacity